Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A T Maiolo

Showing results (41-50 of 91) with videos related to

Pageof 10
Sort By:
European Journal of Cancer & Clinical Oncology|July 1, 1987
Idarubicin in sequential combination with cytosine arabinoside in the treatment of relapsed and refractory patients with acute non-lymphoblastic leukemiaG Lambertenghi-Deliliers, A T Maiolo, C Annaloro, et al.
Nucleic Acids Research|June 25, 1995
Structural and functional characterization of the promoter regions of the NFKB2 geneL Lombardi, P Ciana, C Cappellini, et al.
Annali Italiani Di Medicina Interna : Organo Ufficiale Della Societa Italiana Di Medicina Interna|December 22, 1998
Long-term results in non randomized patients with acute myelogenous leukemia: a single institution experienceG L Deliliers, C Annaloro, A Oriani, et al.
The International Journal of Biological Markers|January 1, 1990
Immunoreactive calcitonin: a tumor marker for myelogenous leukemiasP Foa, S Ortolani, E M Pogliani, et al.
Haematologica|October 12, 2000
Factors predicting response to splenectomy in adult patients with idiopathic thrombocytopenic purpuraF Radaelli, P Faccini, M Goldaniga, et al.
British Journal of Haematology|June 1, 1996
p53 tumour suppressor gene and RAS oncogenes: molecular analysis in the chronic and leukaemic phases of essential thrombocythaemiaA Neri, N S Fracchiolla, F Radaelli, et al.
Blood|February 1, 1985
Prognostic significance of immunoglobulin phenotype in B cell chronic lymphocytic leukemiaL Baldini, R Mozzana, A Cortelezzi, et al.
British Journal of Haematology|December 31, 1997
Poor prognosis in non-villous splenic marginal zone cell lymphoma is associated with p53 mutationsL Baldini, A Guffanti, L Cro, et al.
Oncogene|April 17, 1997
Constitutive expression of lymphoma-associated NFKB-2/Lyt-10 proteins is tumorigenic in murine fibroblastsP Ciana, A Neri, C Cappellini, et al.
Cancer|December 15, 1984
Plasma and urine cyclic nucleotide levels in patients with neoplastic diseasesM Peracchi, L Lombardi, V Toschi, et al.
Pageof 10

Showing results (41-50 of 91) with videos related to

Sort By:
Pageof 10
European Journal of Cancer & Clinical Oncology|July 1, 1987
Idarubicin in sequential combination with cytosine arabinoside in the treatment of relapsed and refractory patients with acute non-lymphoblastic leukemiaG Lambertenghi-Deliliers, A T Maiolo, C Annaloro, et al.
Nucleic Acids Research|June 25, 1995
Structural and functional characterization of the promoter regions of the NFKB2 geneL Lombardi, P Ciana, C Cappellini, et al.
Annali Italiani Di Medicina Interna : Organo Ufficiale Della Societa Italiana Di Medicina Interna|December 22, 1998
Long-term results in non randomized patients with acute myelogenous leukemia: a single institution experienceG L Deliliers, C Annaloro, A Oriani, et al.
The International Journal of Biological Markers|January 1, 1990
Immunoreactive calcitonin: a tumor marker for myelogenous leukemiasP Foa, S Ortolani, E M Pogliani, et al.
Haematologica|October 12, 2000
Factors predicting response to splenectomy in adult patients with idiopathic thrombocytopenic purpuraF Radaelli, P Faccini, M Goldaniga, et al.
British Journal of Haematology|June 1, 1996
p53 tumour suppressor gene and RAS oncogenes: molecular analysis in the chronic and leukaemic phases of essential thrombocythaemiaA Neri, N S Fracchiolla, F Radaelli, et al.
Blood|February 1, 1985
Prognostic significance of immunoglobulin phenotype in B cell chronic lymphocytic leukemiaL Baldini, R Mozzana, A Cortelezzi, et al.
British Journal of Haematology|December 31, 1997
Poor prognosis in non-villous splenic marginal zone cell lymphoma is associated with p53 mutationsL Baldini, A Guffanti, L Cro, et al.
Oncogene|April 17, 1997
Constitutive expression of lymphoma-associated NFKB-2/Lyt-10 proteins is tumorigenic in murine fibroblastsP Ciana, A Neri, C Cappellini, et al.
Cancer|December 15, 1984
Plasma and urine cyclic nucleotide levels in patients with neoplastic diseasesM Peracchi, L Lombardi, V Toschi, et al.
Pageof 10